ACIP votes to expand recommendation for Pfizer’s RSV vaccine ABRYSVO to include adults aged 50 – 59 at increased risk of disease
Vote expands existing recommendation, which was for all adults aged 75 and older and high-risk adults aged 60 to 74
Vote expands existing recommendation, which was for all adults aged 75 and older and high-risk adults aged 60 to 74
The National IP Awards recognize outstanding contributions to India’s innovation economy through effective IP creation and commercialization
The Atlan A100 system delivers advanced ventilation technology for adults, pediatric patients, and neonates, revolutionizing care with seamless workflows across hospital departments
Nadda noted that on the basis of economic caste census, 50 crore people were brought under this scheme
Approval based on AEGEAN Phase III trial results which showed a 32% reduction in the risk of recurrence, progression or death vs. neoadjuvant chemotherapy alone
The amalgamation is expected to create a future-ready, diversified CDMO platform with a technology-led focus across three high-growth verticals-Antibody Drug Conjugates
Nadda noted that TB treatment coverage in India has increased from 59% to 85%
TB treatment coverage in India increased by 32% in the last eight years from 53% in 2015 to 85% in 2023
Experts urge early detection & better access to care
Nadda also commended the role of ASHA workers, “grassroot foot soldiers”, in the healthcare system
Subscribe To Our Newsletter & Stay Updated